StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) income statement

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
43.5%
Operating margin
24.8%
Net margin
40.2%
Return on equity, FY2026
58.9%

Financial strength

Current ratio
3.76
Debt to equity
–
Debt to assets
–
Cash to current liabilities
127.9%

Valuation

P/E ratio
5.0
Price to sales
2.01
Price to book
2.70
Dividend yield
–

See a number that looks wrong?